Literature DB >> 12729341

Diabetes modifies the male:female ratio in pulmonary tuberculosis.

C Pérez-Guzmán1, M H Vargas, A Torres-Cruz, J R Pérez-Padilla, M E Y Furuya, H Villarreal-Velarde.   

Abstract

SETTING: Socio-cultural factors have been invoked to explain the male predominance among patients with pulmonary tuberculosis, but there is no conclusive evidence of their role.
OBJECTIVE: To assess male predominance in a group of diabetics with pulmonary tuberculosis compared with patients with pulmonary tuberculosis alone.
DESIGN: Clinical records of in-patients with pulmonary tuberculosis and with (TBDM group, n = 202) or without (TB group, n = 226) diabetes mellitus were reviewed, and the male percentages in each of six age groups (15-29, 30-39, 40-49, 50-59, 60-69, > or = 70 years) calculated.
RESULTS: In the TB group, no gender difference (51% males) was found in the first age period, followed by a male predominance thereafter (71%, 68%, 75%, 63% and 58%). The TBDM group showed a similar pattern in the first two age groups (56% and 74%), followed by a steadily decline (r(S) = -0.90, P = 0.04) in male percentage (60%, 44%, 45%, 27%), leading to a female predominance after age 50. The association of age and gender was also corroborated by logistic regression in TBDM (P = 0.02), but not in TB (P = 0.19) patients.
CONCLUSIONS: Diabetes was associated with a progressive shift of male predominance in pulmonary tuberculosis. Because diabetes is a disease that affects social activities similarly in men and women, our results suggest that factors other than socio-cultural ones are also important for determining the male predominance in pulmonary tuberculosis.

Entities:  

Mesh:

Year:  2003        PMID: 12729341

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Male-female differences in the risk of tuberculosis in dialysis patients.

Authors:  A I Christopoulos; A A Diamantopoulos; P A Dimopoulos; D S Goumenos; G A Barbalias
Journal:  Int Urol Nephrol       Date:  2008-10-24       Impact factor: 2.370

2.  The relationship between diabetes and tuberculosis in Saskatchewan: comparison of registered Indians and other Saskatchewan people.

Authors:  Roland F Dyck; Helena Klomp; Darcy D Marciniuk; Leonard Tan; Mary Rose Stang; Heather A Ward; Vernon H Hoeppner
Journal:  Can J Public Health       Date:  2007 Jan-Feb

3.  Type 2 diabetes and multidrug-resistant tuberculosis.

Authors:  Susan P Fisher-Hoch; Erin Whitney; Joseph B McCormick; Gonzalo Crespo; Brian Smith; Mohammad H Rahbar; Blanca I Restrepo
Journal:  Scand J Infect Dis       Date:  2008

Review 4.  Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill.

Authors:  Aliasgar Esmail; Natasha F Sabur; Ikechi Okpechi; Keertan Dheda
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

5.  Effect of age on presentation with diabetes: Comparison of nondiabetic patients with new smear-positive pulmonary tuberculosis patients.

Authors:  Jagdish Rawat; Girish Sindhwani; Debasish Biswas
Journal:  Lung India       Date:  2011-07

6.  Tuberculosis and diabetes mellitus - an underappreciated association.

Authors:  Marcin Skowroński; Dorota Zozulińska-Ziółkiewicz; Aleksander Barinow-Wojewódzki
Journal:  Arch Med Sci       Date:  2014-10-23       Impact factor: 3.318

7.  A case control study of risk factors associated with pulmonary tuberculosis in romania: experience at a clinical hospital of pneumology.

Authors:  Pacifique Ndishimye; Bianca Domokos; Jonathan Stillo; Fouad Seghrouchni; Oulaya Mrabet; Daniela Homorodean; Carmen Monica Pop; Abderrahim Sadak
Journal:  Clujul Med       Date:  2017-01-15

8.  Coping with the economic burden of Diabetes, TB and co-prevalence: evidence from Bishkek, Kyrgyzstan.

Authors:  Matthias Arnold; David Beran; Hassan Haghparast-Bidgoli; Neha Batura; Baktygul Akkazieva; Aida Abdraimova; Jolene Skordis-Worrall
Journal:  BMC Health Serv Res       Date:  2016-04-05       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.